VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (2432)	9/16/1997 12:11:00 AM
From: squetch	of 9719

PB, ALLP-Perflubron is Oxyvent-(?) made by ALLP. I will double check tomorrow am. Sleepy now. >>The importance of SOD in the preparation for extrauterine life is substantiated.<< (VD #2386) I am no scientist for sure, so I may be way off base. For some reason this made me recall a surfracant trial. My recollection is surfracant is missing in ARDS patients. Seemed logical to improving condition by replacing surfracant. In the PIII results I saw, surfracant showed zero difference vs placebo in 4 endpoints like survival and time on ventilator. Regards, squetch

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next